Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Flexion Therapeutics reports positive results from study of Zilretta in OA patients with diabetes

Nov. 2, 2016

AbbVie discloses TNF-alpha modulators

Nov. 2, 2016

AbbVie discloses novel TNF-alpha modulators

Oct. 31, 2016

FDA issues complete response letter for sarilumab for rheumatoid arthritis

Oct. 31, 2016

First phase IIa trial of Medivir's MIV-711 fully enrolled, cleared to procede

Oct. 28, 2016

MYH3 gene variants may cause congenital scoliosis

Oct. 27, 2016

Boehringer Ingelheim discloses topline data from phase III trial of BI-695501

Oct. 27, 2016

Genetic variants in genes related to pain sensitivity may have a role in EDS

Oct. 25, 2016

Merck & Co. patents BTK inhibitors

Oct. 24, 2016

Merck & Co. describes novel azacarbazole derivatives

Oct. 21, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Pleased to own ya, Kelonia: Lilly’s $7B CAR T deal
BioWorld
The already-thriving CAR T space took another big stride forward as Eli Lilly and Co. disclosed its plan to acquire Boston-based Kelonia Therapeutics Inc. for as...